CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The new online Learning Center with new content can still be found under the “Training” folder on ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...